approved EB-2 (NIW)

Scientist

Bioengineering · China · 2025-02-05

Processing Time
369 days
Decision Date
2025-02-05
Location
Washington
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance computational algorithms and experimental screening techniques to streamline the creation of modular, low-cost, and efficient protein therapeutics. This work focuses on improving the stability and production of drugs like antibodies and insulins to eliminate cold-chain transportation barriers and reduce healthcare costs.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses significant limitations in the pharmaceutical landscape, specifically high costs and distribution challenges for life-saving therapies.

2 Well-positioned to Advance the Endeavor Met

The petitioner's scholarly output of 8 total publications and 458 citations, along with significant federal funding, demonstrates a track record of success.

3 Balance of Interests/Waiver Benefit Met

The petitioner's unique contributions to biomedical research and drug testing methodology make it beneficial to waive the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 6 peer-reviewed journal articles and 2 preprints, which garnered 458 citations. The case was further supported by research funding from major federal agencies including the NIH, NIAID, and the Department of Defense, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 292 days 2025-02-27
The petitioner proposes to develop engineering approaches for the production of therapeutic antibodies and novel antibody-like proteins. Her work focuses on improving clinical outcomes in oncology, immunology, and anti-infection applications by creating tools to overcome therapeutic resistance and metastasis. Additionally, she aims to enhance production efficiency to ensure broader accessibility of life-saving treatments.

Scientist

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
Ohio 3 days 2024-02-08
The petitioner proposes to continue research on developing new methodologies for engineering and characterizing novel proteins and antibodies. This work aims to further biomedical studies, the biotechnology industry, and healthcare by providing foundations for innovations in therapeutic treatments.

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 5 days 2024-03-20
The petitioner proposes to continue her research on developing biomanufacturing processes to produce therapeutic moieties such as biologics, small molecules, and cell and gene therapies. Her work focuses on achieving optimal-quality treatments for diseases including cancer, inflammation, and rare diseases while expanding the availability of top-tier therapies through biomanufacturing innovations.

Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 476 days 2025-03-14
The petitioner proposes to continue research in structural biology and drug discovery, specifically focusing on the three-dimensional structures of human membrane proteins linked to rare diseases. This work involves using cryo-electron microscopy and mammalian host cells to identify critical features for developing innovative antibodies and small-molecule inhibitors. The goal is to advance targeted treatment strategies for infectious diseases, cancer, and rare conditions.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-05.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 369 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist